Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
27.1M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
23.3M
-
Shares change
-
+677K
-
Total reported value, excl. options
-
$558M
-
Value change
-
+$17.2M
-
Put/Call ratio
-
1.03
-
Number of buys
-
68
-
Number of sells
-
-47
-
Price
-
$23.97
Significant Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q1 2023
144 filings reported holding ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock as of Q1 2023.
Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.3M shares
of 27.1M outstanding shares and own 85.94% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (4.78M shares), STATE STREET CORP (2.24M shares), ARK Investment Management LLC (1.99M shares), BlackRock Inc. (1.8M shares), VANGUARD GROUP INC (1.47M shares), Sumitomo Mitsui Trust Holdings, Inc. (1.42M shares), Nikko Asset Management Americas, Inc. (1.42M shares), BANK OF AMERICA CORP /DE/ (999K shares), FMR LLC (828K shares), and Woodline Partners LP (818K shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.